# Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy

> **NCT00505505** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 800 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage
- Traumatic Brain Injury
- Intracranial Hemorrhage

## Interventions

- **DRUG:** Insulin (Actrapid)

## Key facts

- **NCT ID:** NCT00505505
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2008-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505505, "Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00505505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*